Mitochondrial Enzyme Detailed

Researchers reveal clues regarding how an ancient mitochondrial enzyme helps maintain healthy cells across the tree of life.

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Structure of nicotinamide nucleotide transhydrogenase (TH)IMAGE BY JOSEPHINE LEUNG, COURTEST OF THE STOUT LAB, SCRIPPS RESEARCH INSTITUTENicotinamide nucleotide transhydrogenase (TH), an evolutionarily conserved enzyme that has recently been linked to diabetes and cancer, plays a role in the pumping of protons across the mitochondrial membrane. Similar to the process that drives the production of ATP, TH enzymes support the flow of protons back through the membrane to create NADPH, a compound important for defusing oxygen free radicals. In a study published this week (January 8) in Science, researchers at Scripps Research Institute and elsewhere detail the complete structure of TH, providing clues regarding its precise mechanism of action in this process.

Using technology developed by Vadim Cherezov at University of Southern California, the Scripps team solved the crystal structure of the transmembrane portion of the TH enzyme at 2.8 angstroms resolution. The researchers also imaged crystals of the entire enzyme at lower resolution. The results confirmed that TH exists as a dimer, with two highly flexible copies bound together at varying orientations. The work also revealed a domain on each copy just inside the mitochondrial membrane that binds the NADPH precursor NADP+.

“Our most striking finding was that the two domain III structures are not symmetric—one of them faces up while the other faces down,” lead author Josephine Leung, a graduate student in the lab of Scripps researcher C. David Stout, said in a press release. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies